Clinical Scientist in microbiology. Interests: AMR; epidemiology of Gram-negatives; diagnostics for resistance detection. Views my own. @theamrdoc@mstdn.science

Joined March 2021
164 Photos and videos
Come join us in @UKHSA’s Antimicrobial Resistance and Healthcare Associated Infections Reference Unit - the UK’s national reference laboratory for #AntimicrobialResistance beta.jobs.nhs.uk/candidate/j…
113
🆕💫Antimicrobial Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia Isolates /Europe, Asia,Latin America (2018–2023) 1,287 clinical isolates 71 medical centres 🌎 Aztreonam-avibactam most active 99.5% Bactrim 95.6/96.3% S per CLSI/EUCAST ijidonline.com/article/S1201…
3
18
56
5,530
Katie Hopkins retweeted
The Sanger Prize Competition 2025 - calling for undergraduate students in LMICs The winner will be offered a 3month internship with travel, living and research expenses are all covered by the award. sanger.ac.uk/about/the-sange… #sangerinstitute
24
15
2,402
Katie Hopkins retweeted
PUBLISHED: The 2023-24 English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report gov.uk/government/publicatio… Register to find out more about the findings in the report at the webinar we are hosting on 20th November: antibioticguardian.com/Meeti…
3
22
43
3,880
🆕️🔥Narrative Review @CMIJournal Aztreonam and Avibactam Combination Therapy for Metallo-β-Lactamase-Producing Gram-Negative Bacteria #MBL #IDXposts clinicalmicrobiologyandinfec…
1
60
163
14,648
The increasing report of NDM-producing E. coli isolates that are resistant to either aztreonam-avibactam and/or cefiderocol is major source of concern! Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli #idxposts clinicalmicrobiologyandinfec…

13
29
3,893
Come join us at the UK’s national reference lab for AMR and HCAIs - permanent AfC8b Clinical Scientist role leading Staph and Strep Service. Apply here: beta.jobs.nhs.uk/candidate/j…
5
4
431
Katie Hopkins retweeted
We are running a massive online open course on AMR databases starting end of the month. Its completely free, study at your own pace and its ~15 hours overall over the 3 weeks (although you can finish any time in a year). Please spread in your networks! coursesandconferences.wellco…
7
243
430
52,958
Katie Hopkins retweeted
Exciting times! A big paper I was involved in has dropped @NatureMicrobiol. 100 cases of phage therapy facilitated by a Belgian consortium showing 77.2% clinical improvement. I will go through the results below put please read 👇 nature.com/articles/s41564-0…
13
91
348
36,644
Katie Hopkins retweeted
Join us for an interesting webinar on the challenge of manufacturing and procuring #antibiotics responsibly 🌍 📅5 June, 12-1pm BST 🔗Free registration: page.bsigroup.com/l/73472/20… @BSI_UK @ShionogiUS
6
14
1,533
PLEASE SHARE We're hiring for a permanent HEO role within the AMRHAI Reference Unit! Details: healthjobsuk.com/job/v633452… #AntimicrobialResistance

ALT Eduwis Preschool GIF

1
5
7
612
Responsibilities to include technical work in the in-vitro evaluation of: - novel antimicrobial - antimicrobial susceptibility testing kits - molecular testing kits/systems for detecting resistance determinants - or surveillance of antimicrobial resistance.
86
Katie Hopkins retweeted
We are delivering a 6-part Global Antimicrobial Resistance webinar series with speakers from the UK and countries around the world. If you would like to learn more about webinar 6 - Evaluating an Antimicrobial Stewardship Programme, please click here ow.ly/tJzS50RazYr
1
709
Katie Hopkins retweeted
The updated Bacterial Priority Pathogens List features 15 families of antibiotic-resistant bacteria. To guide the development of new treatments to prevent #AntimicrobialResistance, it sorts them into priorities: 🚨 critical 🔴 high 🟠 medium More about the list and #AMR: bit.ly/4apqHoQ
22
96
191
87,595
WHO publish their 2024 Bacterial Priority Pathogens List: who.int/news/item/17-05-2024… Where does your favourite pathogen sit? #AntimicrobialResistance
1
10
14
909
Katie Hopkins retweeted
27 Apr 2024
#IDTwitter I always thought of SUL-DUR as a 🦀 agent only. I’ve yet to see an NDM E. coli w/ PBP3 mutation, but I’m sure it’s just a matter of time b4 it pops up in Chicago Good to know that durlobactam may work @OncDPharmd @jpogue1 @ryankshields doi.org/10.1093/cid/ciae229
1
12
1,383
In vitro-in vivo discordance in β-lactams activities against MBL producing Enterobacterales has been described 🔥Deciphering the Efficacy of β-Lactams in the Face of MBL Derived Resistance in Enterobacterales Supraphysiologic Zinc in Broth is the Culprit🔥 academic.oup.com/ofid/articl…
3
12
56
32,240